| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Autologous transplantation for multiple myeloma
|
Harousseau, J. -L.
|
|
|
19 |
S7 |
p. vii128-vii133
|
article
|
| 2 |
Balancing costs and benefits in cancer therapy and prevention
|
Szucs, T.D.
|
|
|
19 |
S7 |
p. vii313-vii319
|
article
|
| 3 |
Challenges in treating older cancer patients: breast cancer
|
Wildiers, H.
|
|
|
19 |
S7 |
p. vii99-vii103
|
article
|
| 4 |
Challenges in treating older cancer patients: colon cancer
|
Papamichael, D.
|
|
|
19 |
S7 |
p. vii104-vii108
|
article
|
| 5 |
Challenges treating older non-small cell lung cancer patients
|
Gridelli, C.
|
|
|
19 |
S7 |
p. vii109-vii113
|
article
|
| 6 |
Chemoprevention of breast and prostate cancers: where do we stand?
|
Senn, H.J.
|
|
|
19 |
S7 |
p. vii234-vii237
|
article
|
| 7 |
Chronic lymphocytic leukaemia: a short overview
|
Montserrat, E.
|
|
|
19 |
S7 |
p. vii320-vii325
|
article
|
| 8 |
Clinical cancer control and prevention. Eliminating tobacco-induced cancers: a worldwide challenge
|
Bettcher, D.W.
|
|
|
19 |
S7 |
p. vii230-vii233
|
article
|
| 9 |
Combining immunotherapy with classical anticancer therapy
|
Zwierzina, H.
|
|
|
19 |
S7 |
p. vii252-vii255
|
article
|
| 10 |
Editorial Board
|
|
|
|
19 |
S7 |
p. ii-v
|
article
|
| 11 |
Endometrial cancer: adjuvant treatment of endometrial cancer—radiotherapy, chemotherapy or both
|
Reed, N.
|
|
|
19 |
S7 |
p. vii67-vii69
|
article
|
| 12 |
Erythropoetic-stimulating agents: where do we stand?
|
Dicato, M.
|
|
|
19 |
S7 |
p. vii137-vii140
|
article
|
| 13 |
ESMO Education
|
|
|
|
19 |
S7 |
p. vii5-vii7
|
article
|
| 14 |
ESMO Educational and Scientific activites
|
|
|
|
19 |
S7 |
p. vii10-vii11
|
article
|
| 15 |
ESMO Fellowship Program
|
|
|
|
19 |
S7 |
p. vii13-vii15
|
article
|
| 16 |
ESMO-MORA
|
|
|
|
19 |
S7 |
p. vii8-vii9
|
article
|
| 17 |
European Society for Medical Oncology Committees
|
|
|
|
19 |
S7 |
p. vii17-vii18
|
article
|
| 18 |
Frequently asked questions in the medical management of high-grade glioma: a short guide with practical answers
|
Stupp, R.
|
|
|
19 |
S7 |
p. vii209-vii216
|
article
|
| 19 |
Handling side-effects of targeted therapies: safety of targeted therapies in solid tumours
|
Elez, E.
|
|
|
19 |
S7 |
p. vii146-vii152
|
article
|
| 20 |
How and why to perform a geriatric assessment in clinical practice
|
Terret, C.
|
|
|
19 |
S7 |
p. vii300-vii303
|
article
|
| 21 |
Imaging in glioma
|
Herholz, K.
|
|
|
19 |
S7 |
p. vii207-vii208
|
article
|
| 22 |
Inflammation and cancer prevention
|
Puntoni, M.
|
|
|
19 |
S7 |
p. vii225-vii229
|
article
|
| 23 |
Introducing new molecular technologies into routine clinical cancer care: is there an impact on the treatment of breast cancer?
|
Bianchini, G.
|
|
|
19 |
S7 |
p. vii177-vii183
|
article
|
| 24 |
Introducing new molecular technologies into routine clinical cancer care. What new technology and what for?
|
Mackay, J.
|
|
|
19 |
S7 |
p. vii173-vii176
|
article
|
| 25 |
Introduction
|
Stahel, Rolf A.
|
|
|
19 |
S7 |
p. vii22
|
article
|
| 26 |
Learning can be fun
|
|
|
|
19 |
S7 |
p. vii327-vii329
|
article
|
| 27 |
Low-grade glioma: a challenge in therapeutic options: the role of radiotherapy
|
Baumert, B.G.
|
|
|
19 |
S7 |
p. vii217-vii222
|
article
|
| 28 |
Lung cancer: new opportunities—changing algorithm in staging
|
Weder, W.
|
|
|
19 |
S7 |
p. vii28-vii30
|
article
|
| 29 |
Management of weight loss and anorexia
|
Hopkinson, J.B.
|
|
|
19 |
S7 |
p. vii289-vii293
|
article
|
| 30 |
Mucositis in the treatment of haematological malignancies
|
Niscola, P.
|
|
|
19 |
S7 |
p. vii141-vii145
|
article
|
| 31 |
Multimodality treatment in locoregional gynecological cancer: cervical cancer treatment update
|
Poveda, A.
|
|
|
19 |
S7 |
p. vii70-vii76
|
article
|
| 32 |
Newer opportunities in systemic therapy of lung cancer
|
Rajan, A.
|
|
|
19 |
S7 |
p. vii31-vii37
|
article
|
| 33 |
Novel agents in the era of targeted therapy: what have we learned and how has our practice changed?
|
Baselga, J.
|
|
|
19 |
S7 |
p. vii281-vii288
|
article
|
| 34 |
Novel tools in radiotherapy
|
Spoelstra, F.O.B.
|
|
|
19 |
S7 |
p. vii294-vii299
|
article
|
| 35 |
Optimizing approaches to head and neck cancer. Metastatic head and neck cancer: new options
|
Licitra, L.
|
|
|
19 |
S7 |
p. vii200-vii203
|
article
|
| 36 |
Optimizing approaches to head and neck cancer: strengths and weaknesses in multidisciplinary treatments of locally advanced disease
|
Giralt, J.
|
|
|
19 |
S7 |
p. vii195-vii199
|
article
|
| 37 |
Optimizing approaches to head-and-neck cancers Viruses in head-and-neck cancers: prevention and therapy
|
Psyrri, A.
|
|
|
19 |
S7 |
p. vii189-vii194
|
article
|
| 38 |
Ovarian cancer: front-line standard treatment in 2008
|
Vasey, P.A.
|
|
|
19 |
S7 |
p. vii61-vii66
|
article
|
| 39 |
Overcoming immunosuppressive mechanisms
|
Widén, K.
|
|
|
19 |
S7 |
p. vii241-vii247
|
article
|
| 40 |
Perioperative management of pancreatic cancer
|
Heinemann, V.
|
|
|
19 |
S7 |
p. vii273-vii278
|
article
|
| 41 |
Prognostic factors for multiple myeloma in the era of novel agents
|
Bladé, J.
|
|
|
19 |
S7 |
p. vii117-vii120
|
article
|
| 42 |
Progress in the multidisciplinary treatment of gastrointestinal cancer and the impact on clinical practice: perioperative management of rectal cancer
|
Cervantes, A.
|
|
|
19 |
S7 |
p. vii266-vii272
|
article
|
| 43 |
Progress in the multidisciplinary treatment of gastrointestinal cancers, impact on clinical practice: peri-operative management of gastro-esophageal cancer
|
Okines, A.
|
|
|
19 |
S7 |
p. vii259-vii265
|
article
|
| 44 |
33rd ESMO Congress Officers
|
|
|
|
19 |
S7 |
p. vii19-vii20
|
article
|
| 45 |
33rd ESMO Congress Officers
|
|
|
|
19 |
S7 |
p. vii326
|
article
|
| 46 |
33rd ESMO Congress Organization
|
|
|
|
19 |
S7 |
p. vii21
|
article
|
| 47 |
Recent progress in immunotherapy: anti-cancer vaccines, emerging clinical data
|
Dalgleish, A.G.
|
|
|
19 |
S7 |
p. vii248-vii251
|
article
|
| 48 |
Screening for lung cancer, an ongoing debate
|
Postmus, P.E.
|
|
|
19 |
S7 |
p. vii25-vii27
|
article
|
| 49 |
State-of-the-art approach in selective curable tumors: bone sarcoma
|
Bielack, S.S.
|
|
|
19 |
S7 |
p. vii155-vii160
|
article
|
| 50 |
State-of-the-art approach in selective curable tumors: germ cell tumors
|
Rustin, G.
|
|
|
19 |
S7 |
p. vii161-vii165
|
article
|
| 51 |
State-of-the-art approach in selective curable tumours: soft tissue sarcoma
|
Judson, I.
|
|
|
19 |
S7 |
p. vii166-vii169
|
article
|
| 52 |
Systemic chemotherapy and new experimental approaches in the treatment of metastatic prostate cancer
|
Sternberg, C.N.
|
|
|
19 |
S7 |
p. vii91-vii95
|
article
|
| 53 |
Table of Contents
|
|
|
|
19 |
S7 |
p. vi-vii
|
article
|
| 54 |
The changing face of hormonal therapy for prostate cancer
|
Seruga, B.
|
|
|
19 |
S7 |
p. vii79-vii85
|
article
|
| 55 |
The role of novel drugs in multiple myeloma
|
Dimopoulos, M.A.
|
|
|
19 |
S7 |
p. vii121-vii127
|
article
|
| 56 |
The treatment of advanced pancreatic cancer: current evidence and future challenges
|
Moore, M.J.
|
|
|
19 |
S7 |
p. vii304-vii308
|
article
|
| 57 |
Thymic malignancies
|
Smit, E.F.
|
|
|
19 |
S7 |
p. vii309-vii312
|
article
|
| 58 |
Treament-related diabetes and cardiovascular disease in prostate cancer survivors
|
Smith, M.R.
|
|
|
19 |
S7 |
p. vii86-vii90
|
article
|
| 59 |
Treatment tailoring based on molecular characterizations
|
Dinh, P.
|
|
|
19 |
S7 |
p. vii46-vii50
|
article
|
| 60 |
What is the role and impact of molecular markers on treatment decisions in the adjuvant setting of colorectal cancer?
|
Johnstone, E.C.
|
|
|
19 |
S7 |
p. vii184-vii186
|
article
|
| 61 |
Which tools can I use in daily clinical practice to improve tailoring of treatment for breast cancer? The 2007 St Gallen guidelines and/or Adjuvant! Online
|
Čufer, T.
|
|
|
19 |
S7 |
p. vii41-vii45
|
article
|
| 62 |
Which tools can I use in daily clinical practice to improve tailoring of treatment for breast cancer? Treatment decision-making in advanced disease
|
Smith, I.E.
|
|
|
19 |
S7 |
p. vii51-vii57
|
article
|
| 63 |
Young Oncologists
|
|
|
|
19 |
S7 |
p. vii16
|
article
|
Journal description